The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
In some countries, this medicine may only be approved for veterinary use.
CAS registry number (Chemical Abstracts Service)
Antibacterial: Gyrase inhibitor
3-Quinolinecarboxylic acid, 6-fluoro-1-(4-fluorophenyl)-1,4dihydro-4-oxo7-(1-piperazinyl)- (USAN)
6-fluoro-1-(p-fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline-carboxylic acid (WHO)
- Sarafloxacinum (Latin)
- Sarafloxacin (German)
- Sarafloxacine (French)
- Sarafloxacino (Spanish)
- A-57135 (IS: Abbott)
- Sarafloxacin Hydrochloride (OS: USAN, BAN, USAN)
- A 56620 (IS: Abbott)
- Sarafin (veterinary use)
Vetrepharm, United Kingdom
|BAN||British Approved Name|
|IUPAC||International Union of Pure and Applied Chemistry|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
|WHO||World Health Organization|
Click for further information on drug naming conventions and International Nonproprietary Names.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.